Genomics England

Genomics England

Wholly owned company of the department of health set up to deliver the 100,000 genomes project.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2017201820192020202120222023
Revenues1.2m<1m2.9m3.6m10.5m26.0m27.8m
% growth47 %(74 %)865 %24 %192 %147 %7 %
EBITDA(57.0m)(95.2m)(69.9m)(60.3m)(85.1m)(86.4m)(100m)
% EBITDA margin(4890 %)(31468 %)(2394 %)(1669 %)(808 %)(332 %)(361 %)
Profit(41.4m)(60.3m)(99.3m)(78.2m)(66.4m)(91.4m)(104m)
% profit margin(3556 %)(19938 %)(3402 %)(2166 %)(631 %)(351 %)(376 %)
R&D budget---(1.2m)(<1m)--
R&D % of revenue---(32 %)(9 %)--

Source: Dealroom estimates

Recent News about Genomics England

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Genomics England

Edit
Seven Bridges
ACQUISITION by Velsera Jan 2023